跳至主要内容
临床试验/NL-OMON42249
NL-OMON42249已完成不适用

Systemic fibrinolysis in women with menorrhagia - Menorrhagia and systemic fibrinolysis

niversitair Medisch Centrum Groningen0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Healthy controls with regular menstrual blood loss.
  • Age >=18 years.
  • Written informed consent.
  • - Patients with regular heavy menstrual bleeding (=menorrhagia).
  • Age >=18 years.
  • Written informed consent.

排除标准

  • - Healthy controls with:
  • 1. postmenopausal, postcoital or intermenstrual bleeding.
  • 2. an intra-uterine device or hormonal treatment.
  • 3. anticoagulant, antithrombotic therapy or use of non-steroidal anti-inflammatory drugs (NSAID*s).
  • 4. a Body Mass Index >30 kg/m2.
  • - Patients with:
  • 1. postmenopausal, postcoital or intermenstrual bleeding
  • 2. an intra-uterine device or hormonal treatment.
  • 3. anticoagulant, antithrombotic therapy or use of non-steroidal anti-inflammatory drugs (NSAID*s).
  • 4. uterine fibroids > 2 cm in diameter.
  • 5. a Body Mass Index >30 kg/m2.
  • 6. PBAC-score <200 points.

研究者

相似试验